CME Group Investment and other (expense) income, net decreased by 21.8% to $1.39B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.6%, from $892.70M to $1.39B. Over 4 years (FY 2021 to FY 2025), Investment and other (expense) income, net shows an upward trend with a 107.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Positive values indicate effective treasury management or successful non-core investments, while negative values may indicate financial costs or investment losses.
This captures income or expenses derived from non-core activities, such as interest income, investment returns, or other...
Standard non-operating line item; comparable across most corporate entities.
other_investment_income_nonoperating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.40M | $145.80M | $67.80M | $73.10M | $286.90M | $686.20M | $1.15B | $1.36B | $1.57B | $1.27B | $1.08B | $1.07B | $1.04B | $1.03B | $936.50M | $892.70M | $1.52B | $1.55B | $1.78B | $1.39B |
| QoQ Change | — | +133.7% | -53.5% | +7.8% | +292.5% | +139.2% | +67.9% | +17.8% | +15.5% | -18.9% | -15.4% | -0.5% | -2.5% | -1.7% | -8.8% | -4.7% | +70.1% | +2.0% | +14.7% | -21.8% |
| YoY Change | — | — | — | — | +359.8% | +370.6% | >999% | >999% | +446.6% | +85.4% | -6.5% | -21.1% | -33.4% | -19.3% | -13.0% | -16.7% | +45.4% | +50.8% | +89.7% | +55.6% |